news
Clariant expands in medical
Clariant is to expand its pre-coloured medical plastics compounds production capacity at Lewiston, in Maine in the US, to satisfy growing demand for the products, which it supplies under the Mevopur name. The investment will see
the company install a new compounding line able to produce batch sizes of 3-6 tonnes at high throughput rates. It is due to be on stream in the final quarter of this year. Production will focus on polyolefins, ABS, PC and its alloys. The Lewiston facility is
one of three Clariant sites producing materials for medical devices and pharmaceutical packaging. The other two are at Malmö in Sweden and Singapore, which typically produce lot sizes of 25 kg to 2.5 tonnes. ❙
www.clariant.com
Luxus/JLR share Recyclite auto compound results
UK-based compounder Luxus marked the end of the €1.4m three-year Recyclite project last month together with project partners car maker Jaguar Land Rover, automotive moulder IAC and extruder maker Coperion. Funded in part through the
EU’s Eco-Innovation pro- gramme, the Recyclite project aimed to develop formulations and processing technology for commercial production of a series of lightweight and scratch-resistant PP com- pounds – marketed as Hycolene – containing some recycled content and suitable for use in Class A automotive interior applications. According to Luxus Managing Director Peter Atterby, the development team has achieved all its goals. He said some 60 tonnes of Hycolene compounds have been produced to date on its Coperion twin screw com-
Hycolene delivers environmental performance and improved aesthetics
pounding plant. The project partners have
developed a range of formula- tions offering weight savings of between 2.5-11.0%, recycled contents up to 50%, and considerably improved scratch performance; Erichsen scratch performance ∆L results are less than 0.5 for most grades and in some cases yield negative values (meaning the scratches show darker than the main substrate). Pricing is also said to be competitive.
Plas-Tech sets up Equinox
Plas-Tech Engineering, a custom moulder of medical devices and diagnostic components based at Lake Geneva in Wisconsin, US, has set up a stand-alone subsidiary called Equinox Medical to make pre-filled syringes for the pharmaceutical industry. Equinox will offer pre-filled 0.5-3 ml syringes made in
cyclic olefin copolymer from Topas Advanced Polymers for delivery of drugs for diabetes, allergies and ophthalmic solutions. It is also developing 5 and 10 ml syringes. Plas-Tech said the move is a response to strong
customer demand from emerging biotech and drug companies for a low-volume syringe supplier offering fast speed to market. ❙
www.plastechengineering.com
12 INJECTION WORLD | January/February 2017
Prefilled syringes
produced in COC by
Plas-Tech’s
new Equinox Medical subsidiary
Jaguar Land Rover
Materials Innovation Manager Robert Crow said that trials carried out by IAC on a steering cowl cover for the Range Rover Evoque model using a 40% recycled content Hycolene grade showed a 3.8% weight saving and a 7.6% reduction in environmental impact with a considerable improvement in scratch resistance. IAC reported an up to 10% saving in cycle time. ❙
www.luxus.co.uk
Billion targets US
French injection machinery maker Billion has opened a sales and service office in Detroit in the US. The company says that its all-electric and multi-com- ponent moulding machines are particularly well suited to the local automotive market. The new office will be headed up by John-Paul Mead. ❙
www.billion.fr
www.injectionworld.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70